Revenue and Profitability - Revenue for Q1 2025 was CNY 434.64 million, an increase of 9.18% compared to CNY 398.09 million in the same period last year[5] - The net profit for the current period was -¥12,314,594.94, an improvement from -¥17,342,283.16 in the previous period, indicating a reduction in losses[20] - The company reported a decrease in financial expenses, with interest expenses dropping to ¥55,339,224.18 from ¥64,773,193.69, a decline of 14.5%[19] - The total comprehensive income for the current period was -¥12,314,594.94, an improvement from -¥17,342,283.16 in the previous period, reflecting a positive trend in overall financial performance[20] Cash Flow and Operating Activities - Net cash flow from operating activities improved by 51.56%, reaching CNY -626.43 million compared to CNY -1.29 billion in the previous year[5] - The cash flow from operating activities showed a net outflow of -¥626,428,292.09, compared to -¥1,293,181,267.03 in the previous period, representing a significant improvement[22] - The company generated cash inflows from operating activities totaling ¥1,283,499,450.42, compared to ¥907,863,683.57 in the previous period, an increase of 41.3%[22] - Cash received from operating activities decreased by 38.83% compared to the previous year, primarily due to a reduction in various deposits received[13] Assets and Liabilities - Total assets decreased by 6.49% to CNY 18.60 billion from CNY 19.90 billion at the end of the previous year[5] - Current assets decreased from CNY 9,819,936,337.69 to CNY 8,233,531,917.22, representing a reduction of about 16.1%[17] - Cash and cash equivalents dropped from CNY 3,804,262,383.75 to CNY 2,805,361,940.90, a decrease of approximately 26.2%[17] - Total liabilities decreased from CNY 14,872,870,527.86 to CNY 13,548,062,846.08, a reduction of approximately 8.9%[18] - Current liabilities decreased from CNY 8,973,712,963.81 to CNY 7,465,631,566.12, representing a decline of about 16.8%[18] Research and Development - R&D expenses increased by 269.51% year-on-year, indicating a significant rise in investment in research and development[13] - Research and development expenses increased to ¥4,652,452.97 from ¥1,259,099.20, marking a rise of 270.5%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 46,015[12] - The company raised ¥47,435,000.00 from minority shareholders during the current period, indicating ongoing support for its capital structure[24] Government Subsidies - The total amount of government subsidies recognized in the current period was CNY 2.64 million[6] Other Financial Metrics - The company's weighted average return on equity improved to -0.21% from -0.41% year-on-year[5] - The total amount of contract liabilities rose from CNY 1,874,579,137.95 to CNY 1,941,392,230.66, an increase of approximately 3.6%[18] - The company reported a 100% increase in cash received from investments, attributed to increased external investments[13]
新疆交建(002941) - 2025 Q1 - 季度财报